Clinical trial · Observational
Rutgers University Study of the Genetics of Blood Cancers
The Rutgers University Study of the Genetics of Blood Cancers
NCT07714044CI-TRIAL-00118643recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.
Conditions
Conditions (8)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Blood Cancers | — | UNRESOLVED | — |
| Hematologic Cancer | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
| Hematologic Malignancies | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
| Hematologic Neoplasm | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
| Hematologic Tumors | — | UNRESOLVED | — |
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Myeloma | Multiple Myeloma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Cases
- description
- Persons with blood cancer
- label
- Controls
- description
- Persons who do not have blood cancer
Primary outcomes (1)
- measure
- Genetic risk variants associated with blood cancer
- timeFrame
- 2 years
- description
- Genetic factors will be measured through whole exome sequencing and genome-wide genotyping array, and then correlated with blood cancer subtype.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 110 Years
Show eligibility criteria text
Inclusion Criteria: * age 18 years or older * currently living in the United States * have access to the internet and a computer, laptop, tablet or smartphone * willing to provide written informed consent for participation * willing to provide DNA via a saliva sample using a collection kit mailed to your home * willing to complete a survey with questions about health related to the study of blood cancer. Exclusion Criteria: * Not able to meet or fulfill any of the inclusion criteria
References
Publications (0)
Data not yet available
No reference posted for this study.